Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
MedStar Washington Hospital Center Surpasses 500th HeartMate 3 LVAD Implant, Leading the Nation in Cardiac Innovation
-
MUSASHI JAPAN by TAIMATSU Launches “Dual Blades” – A Black Friday Experience Redefining Luxury Craftsmanship
-
ProVen VCT plc: Publication of Prospectus
-
Scope Technologies Corp. Achieves CyberSecure Canada Level 2 Certification, Advancing Its Leadership in Quantum-Resilient Security and Compliance
-
Cytokinetics Supports American Heart Association Initiative to Improve Care for People Living With Hypertrophic Cardiomyopathy
-
Datavault AI Reports 3Q-25 Highlights and Corporate Update
-
Aeries Technology featured in Everest Group's PEAK Matrix for GCC Setup Capabilities 2025 for the Second Year Running
-
CoinLander Surpasses $600K TVL in 23 Days, Signaling Strong Demand for Tokenized Real Estate Debt
-
Four Points Technology Achieves CMMC 2.0 Level 2 Certification
-
VCI Global Declares Special Dividend of V Gallant Shares as Cybersecurity & AI Subsidiary Prepares for Nine-Figure Nasdaq IPO
-
Eshallgo Inc. Highlights Strong Momentum Across Global Shares; Highlights on Recent Operational Developments and Strategic U.S. Expansion
-
Jeffs’ Brands: Jeffs’ Brands Holdings Enters Into a Non-Binding MOU for an Exclusive Multi Continent Distribution Agreement of an Electromagnetic Imaging, AI Homeland Security Technology
-
VCI Global Declares Special Dividend of V Gallant Shares as Cybersecurity & AI Subsidiary Prepares for Nine-Figure Nasdaq IPO
-
Artificial intelligence, authentic risk: AI-powered threats to soar, warn anti-fraud professionals
-
Ensysce Biosciences Secures $4 Million Financing, Unlocking Up to $20 Million in Total Financing to Advance Breakthrough Pain Programs
-
imagine.io Launches VisualScale.ai on Google Cloud Marketplace to Deliver Brand-True, AI-Generated Product Visuals at Scale
-
Rigel Announces Publication of Final 5-year Data on REZLIDHIA® (olutasidenib) in Patients with R/R mIDH1 AML in the Journal of Hematology & Oncology
-
Iron Cap Group Introduces Next-Generation Market Access Engine for Rapid Activation
-
PRA Group to Participate in Upcoming Investor Events
-
Biotheryx Announces Completion of Enrollment in Phase 1a Clinical Trial of BTX-9341 for the Treatment HR+/HER2- Breast Cancer
-
New long-term data reinforces TREMFYA® (guselkumab) as the only IL-23 inhibitor proven to substantially inhibit structural joint damage in active psoriatic arthritis
-
Alembic Raises $145 Million to Accelerate Enterprise Adoption of Causal AI
-
Sonoma Biotherapeutics Announces Transition of Jeff Bluestone, PhD, to Advisor; Appoints Stephen Dilly, MBBS, PhD, as President and Chief Executive Officer
-
Airsys Unveils PowerOne™ AI-Era Cooling Solutions for Modern Data Centers
-
Butterfly Network Launches Compass AI to Power the Next Generation of POCUS Program Management
-
Financial Advisor Shawna Vanaken Moves from Commonwealth to Cetera's Avantax Community of Tax-Focused Financial Professionals
-
Silo Pharma Partners with Allucent to Support Planned FDA Investigational New Drug Application for SPC-15 as a Therapeutic for PTSD
-
Ashvattha Therapeutics to Showcase Topline Phase 2 Data and Recent FDA Alignment at Upcoming Investor and Ophthalmology Meetings
-
Rackspace Technology Appoints Lata Varghese and Phani Kishore Burre to Senior Leadership Roles Driving Cloud and AI Transformation
-
Mitsubishi Shipbuilding Delivers Large Car Ferry KEYAKI to Shin Nihonkai Ferry and Japan Railway Construction, Transport and Technology Agency
-
SK Life Science, Inc. Announces Publication of C035 Study Analyses in Epilepsia and Seizure
-
Kreate Recognized by the Home Depot as Partner of the Year
-
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Third Quarter 2025 Financial Results and Provides Corporate Update
-
Air Senegal Commits to First Boeing 737 MAX Order
-
Safe Pro Group Accelerates Growth Across AI, Drone Services, and Ballistic Divisions Following $20+ Million in Strategic Investments
-
Silverco Mining Engages SGS to Validate and Update Mineral Resource Estimate at the Cusi Property
-
PharmaTher Advances Strategy to Build Next-Generation Ketamine Franchise for Neuropsychiatric Disorders; Secures Exclusive Rights to Evaluate and License Patented Long-Acting Ketamine Program
-
Zodiac Gold Extends Exclusivity Period with Avesoro Resources
-
RETRANSMISSION: Millennial Potash Reports Significant Increase In Resource Estimates: Measured + Indicated Resource is up by 275% and Inferred Resource is increased by 210% at its Flagship Banio Potas
-
Kohler Unveils Pearlized Finish Artist Editions Sink at Design Miami with Immersive Installation by Harry Nuriev of Crosby Studios
-
ADIA Nutrition Inc. Requests SIC Code Update to 2836 (Biological Products) with SEC and OTC Markets
-
Telescope Innovations to Deliver First Self-Driving Lab for Korea's Largest Biopharma Manufacturers Association
-
Dominion Lending Centres Inc. Announces Quarterly Dividend
-
KLAASWOOD Announces Expanded Strategic Partnership with J.M. Thomas Forest Products
-
Dassault Aviation: Ukraine and Rafale
-
LifeMD® to Offer Market-Leading Pricing for GLP-1 Medications Wegovy® and Ozempic® in Continued Collaboration with Novo Nordisk
-
GrubMarket Acquires Procurant, a Leading Software-as-a-Service Provider and Trading Platform for the Fresh Produce Industry
-
TransCode Therapeutics Expands Executive Team with Appointment of Dr. Michel Janicot as Senior Development Officer
-
LUFA says no to government interference in free collective bargaining
-
ICE Launches Latest Phase of its VaR-Based Portfolio Margining Methodology ICE Risk Model 2
